Yaroslav Kizim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yaroslav Kizim has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Diana Zabolotna
State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Science of Ukraine
7 shared publications - Eldar Ismahilov
State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Science of Ukraine
4 shared publications - Dmitry I. Zabolotnyi
State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Science of Ukraine”; Kyiv, Ukraine
3 shared publications - Iryna Tsvirinko
Державна установа «Інститут отоларингології імені А. І. Коломійченка Національної академії медичних наук України
2 shared publications - Natalia Voroshylova
SI “O.S.Kolomiychenko Institute of Otolarynglology, NAMSU”, Kyiv, Ukraine
2 shared publications - Oksana Sulaieva
Medical Laboratory CSD
2 shared publications
Latest Publications
- Open Access
- 31 March 2026
- Published by Bogomolets National Medical University in Ukrainian Scientific Medical Youth Journal
- Vol. 160 (1)
The use of Anti-Reflux therapy in patients with chronic rhinosinusitis associated with Laryngopharyngeal Reflux
Chronic rhinosinusitis is a persistent inflammatory condition of the nasal cavity and paranasal sinuses that lasts for at least three months and affects millions of individuals worldwide, representing a significant clinical and socioeconomic challenge due to its prolonged course, high symptom burden, and substantial recurrence rates even after optimized medical and surgical therapy. Although the disorder is widely recognized as multifactorial, with contributing elements such as impaired epithelial barrier function, altered microbiota composition, genetic susceptibility, environmental exposure, and dysregulated local and systemic immune responses, increasing attention has been directed toward the potential impact of laryngopharyngeal reflux as an overlooked but clinically important factor capable of sustaining inflammation in the upper aerodigestive tract. Experimental and clinical studies have demonstrated that refluxate containing pepsin and other gastric components may reach the nasopharynx and sinonasal mucosa, where it induces epithelial injury, promotes mucous hypersecretion, alters local microbial ecology, and triggers neurogenic inflammatory pathways, ultimately impairing mucociliary transport and facilitating bacterial colonization and secondary infection. Given that unsatisfactory postoperative outcomes remain a considerable problem and that reflux-related mucosal irritation has been implicated in delayed healing and disease persistence, the present study aimed to investigate whether postoperative antireflux treatment may influence symptom dynamics and recurrence rates in patients with chronic rhinosinusitis with or without nasal polyps who also exhibit signs of laryngopharyngeal reflux. A prospective clinical study included 52 patients examined at the Kolomiychenko Institute of Otolaryngology between 2023 and 2024. Patients were divided into two groups: 26 received proton pump inhibitor therapy with antacids in the postoperative period, while 26 did not. All underwent videoendoscopic rhinoscopy, laryngoscopy, and computed tomography of the paranasal sinuses. Symptoms were assessed by the Sino-Nasal Outcome Test-22, endoscopic manifestations by the Lund-Kennedy scoring system, and reflux status by the Reflux Symptom Index and Reflux Finding Score. Preoperatively, groups showed no significant differences. Three months after surgery, patients who received anti-reflux therapy had a significantly lower mean Sino-Nasal Outcome Test-22 score compared with controls, indicating greater symptom reduction, although endoscopic improvements were similar in both groups. During follow-up, recurrence was observed in 19.2% of treated patients and 30.8% of untreated patients, with a trend toward fewer recurrences under therapy, but without statistical significance due to limited sample size and short observation. The results confirm that signs of laryngopharyngeal reflux are common in patients with chronic rhinosinusitis and suggest that anti-reflux therapy may enhance symptom control and possibly reduce recurrence risk after surgery. Larger, long-term studies are needed to clarify the role of reflux management in comprehensive treatment strategies.
- 31 March 2026
- Published by Bogomolets National Medical University in Ukrainian Scientific Medical Youth Journal
- Vol. 160 (1)
Open AccessThe use of Anti-Reflux therapy in patients with chronic rhinosinusitis associated with Laryngopharyngeal Reflux
Chronic rhinosinusitis is a persistent inflammatory condition of the nasal cavity and paranasal sinuses that lasts for at least three months and affects millions of individuals worldwide, representing a significant clinical and socioeconomic challenge due to its prolonged course, high symptom burden, and substantial recurrence rates even after optimized medical and surgical therapy. Although the disorder is widely recognized as multifactorial, with contributing elements such as impaired epithelial barrier function, altered microbiota composition, genetic susceptibility, environmental exposure, and dysregulated local and systemic immune responses, increasing attention has been directed toward the potential impact of laryngopharyngeal reflux as an overlooked but clinically important factor capable of sustaining inflammation in the upper aerodigestive tract. Experimental and clinical studies have demonstrated that refluxate containing pepsin and other gastric components may reach the nasopharynx and sinonasal mucosa, where it induces epithelial injury, promotes mucous hypersecretion, alters local microbial ecology, and triggers neurogenic inflammatory pathways, ultimately impairing mucociliary transport and facilitating bacterial colonization and secondary infection. Given that unsatisfactory postoperative outcomes remain a considerable problem and that reflux-related mucosal irritation has been implicated in delayed healing and disease persistence, the present study aimed to investigate whether postoperative antireflux treatment may influence symptom dynamics and recurrence rates in patients with chronic rhinosinusitis with or without nasal polyps who also exhibit signs of laryngopharyngeal reflux. A prospective clinical study included 52 patients examined at the Kolomiychenko Institute of Otolaryngology between 2023 and 2024. Patients were divided into two groups: 26 received proton pump inhibitor therapy with antacids in the postoperative period, while 26 did not. All underwent videoendoscopic rhinoscopy, laryngoscopy, and computed tomography of the paranasal sinuses. Symptoms were assessed by the Sino-Nasal Outcome Test-22, endoscopic manifestations by the Lund-Kennedy scoring system, and reflux status by the Reflux Symptom Index and Reflux Finding Score. Preoperatively, groups showed no significant differences. Three months after surgery, patients who received anti-reflux therapy had a significantly lower mean Sino-Nasal Outcome Test-22 score compared with controls, indicating greater symptom reduction, although endoscopic improvements were similar in both groups. During follow-up, recurrence was observed in 19.2% of treated patients and 30.8% of untreated patients, with a trend toward fewer recurrences under therapy, but without statistical significance due to limited sample size and short observation. The results confirm that signs of laryngopharyngeal reflux are common in patients with chronic rhinosinusitis and suggest that anti-reflux therapy may enhance symptom control and possibly reduce recurrence risk after surgery. Larger, long-term studies are needed to clarify the role of reflux management in comprehensive treatment strategies.
- Open Access
- 1 January 2026
- Published by Vistka LTD
- Vol. 9 (1-2) , 25-31
EFFECTIVENESS OF ETHMOID NASALIZATION IN PATIENTS WITH POLYPOUS RHINOSINUSIS
Chronic rhinosinusitis with nasal polyps (CRSwNP) remains a challenging clinical condition characterized by a high recurrence rate after conventional surgical treatment. Increasing attention has recently been paid to ethmoidal nasalization, a more radical surgical approach targeting inflamed mucosa as a potential source of type‑2 inflammation. Objective: To evaluate the effectiveness of modified ethmoid nasalization compared to classical functional endoscopic sinus surgery (FESS) in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and type 2 inflammation. Materials and methods: Twenty patients with CRSwNP, bronchial asthma, and eosinophilic inflammation (100% type 2) were enrolled. Patients were divided into two groups (n=10 each): group 1 – classical FESS with maximal mucosal preservation; group 2 – modified ethmoid nasalization with complete removal of ethmoid mucosa followed by free mucosal flap coverage from the nasal floor. Quality of life was assessed using the SNOT-22 questionnaire and reverse visual analog scale (VAS, 0-10, higher scores indicate better condition) preoperatively and at 3, 6, and 12 months postoperatively. Statistical analysis was performed using the independent samples t-test. Results: Groups were comparable at baseline (Lund-Mackay score: 22 vs 20; SNOT-22: 60.2 vs 62.6). At 12 months, mean reverse VAS score was 2.1 (95% CI 0.67-3.53) in the FESS group versus 7.1 (95% CI 5.67-8.53) in the nasalization group (p<0.001). SNOT-22 scores at 12 months were 21.4 (95% CI 8.52-34.28) versus 11.1 (95% CI -1.78-23.98), respectively (p=0.217). The most pronounced difference was observed at late follow-up time points, indicating more sustained improvement after nasalization. Conclusions: Modified ethmoid nasalization provides significantly better long-term subjective outcomes in quality of life compared to classical FESS in patients with eosinophilic CRSwNP. The technique appears promising for reducing recurrence rates and the need for systemic corticosteroids and biologic therapy. Keywords: chronic rhinosinusitis with nasal polyps, ethmoid nasalization, functional endoscopic sinus surgery, SNOT-22, visual analog scale, type 2 inflammation.
- 1 January 2026
- Published by Vistka LTD
- Vol. 9 (1-2) , 25-31
Open AccessEFFECTIVENESS OF ETHMOID NASALIZATION IN PATIENTS WITH POLYPOUS RHINOSINUSIS
Chronic rhinosinusitis with nasal polyps (CRSwNP) remains a challenging clinical condition characterized by a high recurrence rate after conventional surgical treatment. Increasing attention has recently been paid to ethmoidal nasalization, a more radical surgical approach targeting inflamed mucosa as a potential source of type‑2 inflammation. Objective: To evaluate the effectiveness of modified ethmoid nasalization compared to classical functional endoscopic sinus surgery (FESS) in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and type 2 inflammation. Materials and methods: Twenty patients with CRSwNP, bronchial asthma, and eosinophilic inflammation (100% type 2) were enrolled. Patients were divided into two groups (n=10 each): group 1 – classical FESS with maximal mucosal preservation; group 2 – modified ethmoid nasalization with complete removal of ethmoid mucosa followed by free mucosal flap coverage from the nasal floor. Quality of life was assessed using the SNOT-22 questionnaire and reverse visual analog scale (VAS, 0-10, higher scores indicate better condition) preoperatively and at 3, 6, and 12 months postoperatively. Statistical analysis was performed using the independent samples t-test. Results: Groups were comparable at baseline (Lund-Mackay score: 22 vs 20; SNOT-22: 60.2 vs 62.6). At 12 months, mean reverse VAS score was 2.1 (95% CI 0.67-3.53) in the FESS group versus 7.1 (95% CI 5.67-8.53) in the nasalization group (p<0.001). SNOT-22 scores at 12 months were 21.4 (95% CI 8.52-34.28) versus 11.1 (95% CI -1.78-23.98), respectively (p=0.217). The most pronounced difference was observed at late follow-up time points, indicating more sustained improvement after nasalization. Conclusions: Modified ethmoid nasalization provides significantly better long-term subjective outcomes in quality of life compared to classical FESS in patients with eosinophilic CRSwNP. The technique appears promising for reducing recurrence rates and the need for systemic corticosteroids and biologic therapy. Keywords: chronic rhinosinusitis with nasal polyps, ethmoid nasalization, functional endoscopic sinus surgery, SNOT-22, visual analog scale, type 2 inflammation.
- Open Access
- 23 December 2022
- Published by European Scientific Platform (Publications) in Grail of Science
- No. 23,p. 418-422
MALIGNIZATION AS A CONSEQUENCE OF THE FORMATION OF MICROBIAL RESISTANCE
The ability of microorganisms to form multicellular three-dimensional associates (biofilms) increases significantly their resistance to the influence of negative environmental factors. One of the manifestations of this ability is the development of drug resistance, which leads to a decrease in the effectiveness of drugs and significantly complicates the treatment of the corresponding diseases. Despite the unabated interest in this extremely undesirable phenomenon, there is no generally accepted explanation of the mechanisms of resistance development. At the same time, the generalization of data on the properties of biofilms allows us to get closer to the understanding of this process, but also to substantiate the proposition about its negative impact on adjacent tissues.
- 23 December 2022
- Published by European Scientific Platform (Publications) in Grail of Science
- No. 23,p. 418-422
Open AccessMALIGNIZATION AS A CONSEQUENCE OF THE FORMATION OF MICROBIAL RESISTANCE
The ability of microorganisms to form multicellular three-dimensional associates (biofilms) increases significantly their resistance to the influence of negative environmental factors. One of the manifestations of this ability is the development of drug resistance, which leads to a decrease in the effectiveness of drugs and significantly complicates the treatment of the corresponding diseases. Despite the unabated interest in this extremely undesirable phenomenon, there is no generally accepted explanation of the mechanisms of resistance development. At the same time, the generalization of data on the properties of biofilms allows us to get closer to the understanding of this process, but also to substantiate the proposition about its negative impact on adjacent tissues.
- 22 December 2022
- Published by National Academy of Medical Sciences of Ukraine in JOURNAL OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE
- No. 4 2022,p. 528-542
DRUG RESISTANCE: THE STATUS OF THE PROBLEM AND THE SEARCH OF WAYS TO OVERCOME IT (literature review and own research)
The ability of multicellular associates to undergo changes that provide increased resistance to adverse environmental factors determines the development of drug resistance. Over the past decades, it has turned into a complex medical and social problem, which complicates significantly the treatment of countless diseases. In particular, the rapid formation and spread of antibiotic-resistant forms of microorganisms causes the risk of relegating clinical medicine to the pre-antibiotic era. An equally acute problem is the growing resistance of cells of malignant neoplasms to the action of cytostatics as the tumor progresses and during its recurrence. The obvious relevance of these problems for means of counteracting such changes determines the unabated interest in elucidating the molecular and cellular bases of the development of drug resistance. The existence of a certain parallel in the functioning of the cellular societies of biofilms and malignant neoplasms allows us to approach the understanding of the molecular and cellular mechanisms of the development of drug resistance. The role of disruption of the barrier function of the outer cell membranes and the increase in their permeability to extracellular nucleic components is shown in this process. The role of individual components of cellular associates in the formation of drug-resistant, mechanisms of their spread and malignization of surrounding tissues is discussed. Key words: drug resistance, biofilms, malignant neoplasms, cell membranes.
- 22 December 2022
- Published by National Academy of Medical Sciences of Ukraine in JOURNAL OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE
- No. 4 2022,p. 528-542
DRUG RESISTANCE: THE STATUS OF THE PROBLEM AND THE SEARCH OF WAYS TO OVERCOME IT (literature review and own research)
The ability of multicellular associates to undergo changes that provide increased resistance to adverse environmental factors determines the development of drug resistance. Over the past decades, it has turned into a complex medical and social problem, which complicates significantly the treatment of countless diseases. In particular, the rapid formation and spread of antibiotic-resistant forms of microorganisms causes the risk of relegating clinical medicine to the pre-antibiotic era. An equally acute problem is the growing resistance of cells of malignant neoplasms to the action of cytostatics as the tumor progresses and during its recurrence. The obvious relevance of these problems for means of counteracting such changes determines the unabated interest in elucidating the molecular and cellular bases of the development of drug resistance. The existence of a certain parallel in the functioning of the cellular societies of biofilms and malignant neoplasms allows us to approach the understanding of the molecular and cellular mechanisms of the development of drug resistance. The role of disruption of the barrier function of the outer cell membranes and the increase in their permeability to extracellular nucleic components is shown in this process. The role of individual components of cellular associates in the formation of drug-resistant, mechanisms of their spread and malignization of surrounding tissues is discussed. Key words: drug resistance, biofilms, malignant neoplasms, cell membranes.
- 31 October 2022
- Published by Vistka LTD in OTORHINOLARYNGOLOGY
- No. No5(5) 202,p. 63-70
History and modern aspects of treatment of juvenile nasopharyngeal angiofibroma
Juvenile nasopharyngeal angiofibroma (JNA) is a rare benign tumor that is clinically manifested by epistaxis, usually occurs in males aged 9–27 years and accounts for approximately 0.5% of all head and neck tumors. The article presents historical data on the diagnosis and treatment of JNA. Modern views on the etiology of JNA are also represented. The development of such areas of medicine as anesthesiology (intubation, adequate analgesia and anesthesia, hemosubstitution, resuscitation), neuroradiology, endovascular surgery contributed to a further push in solving the problem of JNA. Attempts to visualize and treat this tumor have accompanied the evolution of the surgical treatment of juvenile nasopharyngeal angiofibroma. Today, the problem of JNA surgery is one of the most controversial and relevant in modern otolaryngology and neurosurgery. The key to this problem is the optimal choice of access to JNA. The article presents the results of treatment of 32 patients with JNA in the State Institution “Kolomiychenko Institute of Otolaryngology of NAMS of Ukraine. All patients underwent surgery by endoscopic endonasal approach. Selective angiography with embolization was performed only in patients with stages II and III according to Fisch classification. Patients with stage I did not receive embolization. The study protocol included CT and MRI examinations with intravenous contrast to determine the diagnosis and determine the stage of the tumor according to Fisch. Tumor recurrence was observed in 2 patients, and these patients had stage II according to Fisch. Tumor recurrence in all cases was observed in the pterygopalatine fossa area.
- 31 October 2022
- Published by Vistka LTD in OTORHINOLARYNGOLOGY
- No. No5(5) 202,p. 63-70
History and modern aspects of treatment of juvenile nasopharyngeal angiofibroma
Juvenile nasopharyngeal angiofibroma (JNA) is a rare benign tumor that is clinically manifested by epistaxis, usually occurs in males aged 9–27 years and accounts for approximately 0.5% of all head and neck tumors. The article presents historical data on the diagnosis and treatment of JNA. Modern views on the etiology of JNA are also represented. The development of such areas of medicine as anesthesiology (intubation, adequate analgesia and anesthesia, hemosubstitution, resuscitation), neuroradiology, endovascular surgery contributed to a further push in solving the problem of JNA. Attempts to visualize and treat this tumor have accompanied the evolution of the surgical treatment of juvenile nasopharyngeal angiofibroma. Today, the problem of JNA surgery is one of the most controversial and relevant in modern otolaryngology and neurosurgery. The key to this problem is the optimal choice of access to JNA. The article presents the results of treatment of 32 patients with JNA in the State Institution “Kolomiychenko Institute of Otolaryngology of NAMS of Ukraine. All patients underwent surgery by endoscopic endonasal approach. Selective angiography with embolization was performed only in patients with stages II and III according to Fisch classification. Patients with stage I did not receive embolization. The study protocol included CT and MRI examinations with intravenous contrast to determine the diagnosis and determine the stage of the tumor according to Fisch. Tumor recurrence was observed in 2 patients, and these patients had stage II according to Fisch. Tumor recurrence in all cases was observed in the pterygopalatine fossa area.
- Open Access
- 30 September 2022
- Published by European Scientific Platform (Publications) in Grail of Science
- No. 20,p. 169-174
OPTIMIZATION OF THE TRANSORAL METHOD OF ACCESS IN PATIENTS WITH NEOPLASMS OF THE PARAPHARYNGEAL SPACE
Primary tumors of the parapharyngeal space are rare and account for up to 0.5% of all neoplasms of the head and neck. 70-80% of these neoplasms are benign, 20-30% are malignant ones. Surgical treatment is the main method of treatment of tumors. The influence of a modified transoral access method on the presence of complications in the postoperative period was investigated. A comparison of various methods of transoral access in patients was carried out, by studying the presence of local complications and quality of life. The advantages of the modified transoral method of access are shown. The obtained results are discussed.
- 30 September 2022
- Published by European Scientific Platform (Publications) in Grail of Science
- No. 20,p. 169-174
Open AccessOPTIMIZATION OF THE TRANSORAL METHOD OF ACCESS IN PATIENTS WITH NEOPLASMS OF THE PARAPHARYNGEAL SPACE
Primary tumors of the parapharyngeal space are rare and account for up to 0.5% of all neoplasms of the head and neck. 70-80% of these neoplasms are benign, 20-30% are malignant ones. Surgical treatment is the main method of treatment of tumors. The influence of a modified transoral access method on the presence of complications in the postoperative period was investigated. A comparison of various methods of transoral access in patients was carried out, by studying the presence of local complications and quality of life. The advantages of the modified transoral method of access are shown. The obtained results are discussed.
- Open Access
- 1 May 2021
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Clinical and Experimental Otorhinolaryngology
- Vol. 14 (2) , 240-243
Laryngopharyngeal Reflux Alters Macrophage Polarization in Human Papilloma Virus-Negative Squamous Cell Carcinoma of the Larynx in Males
- 1 May 2021
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Clinical and Experimental Otorhinolaryngology
- Vol. 14 (2) , 240-243
Open AccessLaryngopharyngeal Reflux Alters Macrophage Polarization in Human Papilloma Virus-Negative Squamous Cell Carcinoma of the Larynx in Males
- 19 January 2021
- Published by Vistka LTD in OTORHINOLARYNGOLOGY
- No. №1(4) 2021,p. 12-19
Clinical and morphological aspects of the LPR-associated cancer of the larynx
Introduction: Squamous cell carcinomas of the head and neck, including laryngeal cancer, rank sixth in prevalence according to world statistics from developed countries. The role of laryngopharyngeal reflux as one of the risk factors for the development of laryngeal cancer remains controversial and needs further study. Objective: To analyze and compare clinical manifestations and morphological data in patients with laryngeal cancer T1-2N0M0 with LPR. Materials and methods: 87 patients with laryngeal cancer of the I-II stage T1-2N0M0. For the purpose of screening diagnostics of LPR, modified visualanalogue scales RSI and RFS were used,24-hour pH-monitoring was performed. To conduct a histopathological study, samples of surgical material were selected from 8 patients with laryngeal cancer of the I-II stage T1-2N0M0 with LPR; 8 patients with laryngeal cancer – without LPR and 8 patients with benign neoplasms of the larynx with LPR. Results: When analyzing the results of the examination, the RSI index exceeded “9” in 39 (44.8%) patients. According to 24-hour pH monitoring, the presence of LPR was diagnosed in 32 (36.8%) examined patients with morphologically verified squamous cell carcinoma of the larynx, which made up the study group. In 6 (75.0%) patients from the comparison group, areas covered by stratified squamous epithelium were determined within the mucous membrane, in 5 (62.5%) patients, transition zones containing both stratified squamous and single-layered multilayer ciliated were determined epithelium. The nature and intensity of lymphohistiocytic infiltration was more expressed in patients with associated LPR.
- 19 January 2021
- Published by Vistka LTD in OTORHINOLARYNGOLOGY
- No. №1(4) 2021,p. 12-19
Clinical and morphological aspects of the LPR-associated cancer of the larynx
Introduction: Squamous cell carcinomas of the head and neck, including laryngeal cancer, rank sixth in prevalence according to world statistics from developed countries. The role of laryngopharyngeal reflux as one of the risk factors for the development of laryngeal cancer remains controversial and needs further study. Objective: To analyze and compare clinical manifestations and morphological data in patients with laryngeal cancer T1-2N0M0 with LPR. Materials and methods: 87 patients with laryngeal cancer of the I-II stage T1-2N0M0. For the purpose of screening diagnostics of LPR, modified visualanalogue scales RSI and RFS were used,24-hour pH-monitoring was performed. To conduct a histopathological study, samples of surgical material were selected from 8 patients with laryngeal cancer of the I-II stage T1-2N0M0 with LPR; 8 patients with laryngeal cancer – without LPR and 8 patients with benign neoplasms of the larynx with LPR. Results: When analyzing the results of the examination, the RSI index exceeded “9” in 39 (44.8%) patients. According to 24-hour pH monitoring, the presence of LPR was diagnosed in 32 (36.8%) examined patients with morphologically verified squamous cell carcinoma of the larynx, which made up the study group. In 6 (75.0%) patients from the comparison group, areas covered by stratified squamous epithelium were determined within the mucous membrane, in 5 (62.5%) patients, transition zones containing both stratified squamous and single-layered multilayer ciliated were determined epithelium. The nature and intensity of lymphohistiocytic infiltration was more expressed in patients with associated LPR.